Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Protein processing in endoplasmic reticulum (mmu04141)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1500019G
21Rik
KLA  ATP  ATP+KLA
 NM_024172 RIKEN cDNA 1500019G21 gene (1500019G21Rik), mRNA [NM_024172] KLA 1.10 1.15 1.24 1.11 1.09 .90 .86
ATP 1.02 1.17 1.00 1.54 1.14 .80 .66
KLA/ATP 1.27 1.31 1.07 1.61 .95 .91 .55
3/6/2009
KLA  ATP  ATP+KLA
 NM_172606 membrane-associated ring finger (C3HC4) 6 (March6), mRNA [NM_172606] KLA .64 .64 .66 .69 .78 .97 .92
ATP 1.06 1.03 1.15 .91 .87 1.12 1.35
KLA/ATP .67 .71 .70 .67 .71 1.20 1.73
4933407N
01Rik
KLA  ATP  ATP+KLA
 NM_025745 RIKEN cDNA 4933407N01 gene (4933407N01Rik), mRNA [NM_025745] KLA 1.08 1.02 1.05 1.04 1.04 1.15 1.11
ATP .99 .80 .83 .78 .87 1.01 1.03
KLA/ATP 1.03 .86 .85 .86 1.17 1.38 1.27
6620401M
08Rik
KLA  ATP  ATP+KLA
 AK029831 adult male testis cDNA, RIKEN full-length enriched library, clone:4931406B08 product:unclassifiable, full insert sequence [AK029831] KLA .94 .90 .86 .95 .67 .52 .31
ATP .95 .89 1.53 1.39 1.08 .90 .55
KLA/ATP .82 .88 1.28 1.10 1.01 .75 .40
AK016943
KLA  ATP  ATP+KLA
 AK016943 adult male testis cDNA, RIKEN full-length enriched library, clone:4933427C01 product:hypothetical Arginine-rich region containing protein, full insert sequence. [AK016943] KLA .94 1.00 .99 .94 .99 1.07 1.06
ATP 1.08 1.03 1.07 1.05 1.00 .98 .99
KLA/ATP 1.02 .95 1.03 1.02 1.08 1.00 1.04
AK030790
KLA  ATP  ATP+KLA
 AK030790 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830401P05 product:unclassifiable, full insert sequence [AK030790] KLA 1.05 .96 1.01 .98 .98 .91 .98
ATP .97 .97 1.04 .92 .99 .92 .98
KLA/ATP 1.01 1.00 1.01 1.08 .93 1.01 1.09
Amfr
KLA  ATP  ATP+KLA
 NM_011787 autocrine motility factor receptor (Amfr), mRNA [NM_011787] KLA 1.13 1.04 1.03 1.09 .94 .86 1.02
ATP 1.02 1.03 1.13 1.10 1.03 1.19 .91
KLA/ATP 1.00 1.11 1.02 1.00 .95 .92 .74
Atf4
KLA  ATP  ATP+KLA
 NM_009716 activating transcription factor 4 (Atf4), mRNA [NM_009716] KLA .91 1.06 1.13 1.31 1.92 2.59 3.01
ATP 1.05 1.14 1.34 2.88 4.84 2.36 2.56
KLA/ATP 1.14 1.08 1.17 2.40 3.72 3.54 3.62
Atf6
KLA  ATP  ATP+KLA
 NM_001081304 activating transcription factor 6 (Atf6), mRNA [NM_001081304] KLA 1.04 1.07 1.07 1.31 1.54 1.46 1.19
ATP 1.04 1.10 1.25 1.15 1.03 1.25 1.49
KLA/ATP .98 1.14 1.31 1.21 1.00 1.10 1.66
Atxn3
KLA  ATP  ATP+KLA
 NM_029705 ataxin 3 (Atxn3), mRNA [NM_029705] KLA .84 .87 .68 .67 .58 .65 .79
ATP .99 1.05 .98 .93 .80 1.02 .88
KLA/ATP .84 .85 .85 .76 .67 .72 .74
BC006751
KLA  ATP  ATP+KLA
 BC006751 cDNA clone IMAGE:3256899, complete cds. [BC006751] KLA 1.11 1.06 .94 1.06 .85 1.09 1.44
ATP .90 .87 1.35 1.29 1.75 2.35 1.33
KLA/ATP .95 1.01 1.42 1.10 1.41 1.52 1.43
Bag1
KLA  ATP  ATP+KLA
 NM_009736 Bcl2-associated athanogene 1 (Bag1), mRNA [NM_009736] KLA .99 1.10 1.09 1.12 1.23 1.26 1.43
ATP .97 1.00 .94 1.23 1.19 .96 1.01
KLA/ATP 1.12 1.14 1.11 1.29 1.19 1.15 1.11
Bag2
KLA  ATP  ATP+KLA
 NM_145392 Bcl2-associated athanogene 2 (Bag2), mRNA [NM_145392] KLA .44 .49 .43 .46 .46 .49 .54
ATP .99 1.00 1.01 .94 .84 .71 .65
KLA/ATP .43 .45 .48 .45 .55 .59 .42
Bak1
KLA  ATP  ATP+KLA
 NM_007523 BCL2-antagonist/killer 1 (Bak1), mRNA [NM_007523] KLA 1.31 1.34 1.44 1.48 1.81 1.82 1.83
ATP 1.11 1.20 1.01 1.21 1.08 1.18 1.66
KLA/ATP 1.42 1.40 1.24 1.47 1.24 1.56 2.66
Bax
KLA  ATP  ATP+KLA
 NM_007527 Bcl2-associated X protein (Bax), mRNA [NM_007527] KLA 1.08 1.14 1.10 1.14 1.17 1.06 .92
ATP 1.06 1.05 1.02 1.25 1.26 .90 .86
KLA/ATP 1.11 1.19 1.30 1.34 1.34 .87 .71
Bcap31
KLA  ATP  ATP+KLA
 NM_012060 B-cell receptor-associated protein 31 (Bcap31), mRNA [NM_012060] KLA .91 .92 .91 .85 .87 .99 1.18
ATP .98 1.05 1.02 1.17 1.09 1.10 1.16
KLA/ATP .90 .99 .94 1.03 .94 .98 1.21
Bcl2
KLA  ATP  ATP+KLA
 NM_009741 B-cell leukemia/lymphoma 2 (Bcl2), transcript variant 1, mRNA [NM_009741] KLA .30 .26 .25 .25 .34 .38 .26
ATP .97 .89 1.50 1.04 .99 .29 .52
KLA/ATP .28 .26 .40 .33 .62 .29 .12
Bcl2
KLA  ATP  ATP+KLA
 NM_177410 B-cell leukemia/lymphoma 2 (Bcl2), transcript variant 2, mRNA [NM_177410] KLA .33 .33 .37 .42 .49 .46 .39
ATP 1.07 1.12 1.22 1.56 1.00 .38 .76
KLA/ATP .35 .34 .54 .89 .76 .36 .23
Calr
KLA  ATP  ATP+KLA
 NM_007591 calreticulin (Calr), mRNA [NM_007591] KLA .86 .95 1.00 .68 .92 .93 1.37
ATP 1.12 1.34 .91 1.33 1.07 .97 1.46
KLA/ATP 1.09 1.02 .63 1.06 .65 .92 1.16
Canx
KLA  ATP  ATP+KLA
 NM_007597 calnexin (Canx), transcript variant 1, mRNA [NM_007597] KLA 1.00 1.01 .92 .87 .85 .86 1.04
ATP 1.00 1.13 .97 1.04 .90 .75 .81
KLA/ATP 1.02 1.10 .82 .90 .63 .55 .60
Capn1
KLA  ATP  ATP+KLA
 NM_007600 calpain 1 (Capn1), transcript variant 1, mRNA [NM_007600] KLA 1.28 1.27 1.46 1.23 1.37 1.27 .99
ATP 1.07 1.24 .99 1.33 .98 .89 1.21
KLA/ATP 1.46 1.49 1.09 1.57 1.03 1.18 1.28
Capn2
KLA  ATP  ATP+KLA
 NM_009794 calpain 2 (Capn2), mRNA [NM_009794] KLA .63 .65 .70 .57 .60 .61 .58
ATP 1.03 1.21 .78 .98 .82 .59 1.19
KLA/ATP .80 .71 .37 .54 .45 .46 1.05
Casp12
KLA  ATP  ATP+KLA
 NM_009808 caspase 12 (Casp12), mRNA [NM_009808] KLA 6.56 6.38 7.54 6.85 5.36 2.61 1.46
ATP .99 .98 1.17 1.56 1.32 1.40 1.13
KLA/ATP 6.27 6.52 5.79 5.68 3.74 2.21 1.78
Ckap4
KLA  ATP  ATP+KLA
 NM_175451 cytoskeleton-associated protein 4 (Ckap4), mRNA [NM_175451] KLA .52 .52 .36 .36 .26 .23 .38
ATP .97 .86 1.05 .96 .87 .77 1.11
KLA/ATP .49 .50 .56 .44 .53 .50 .39
Crebl1
KLA  ATP  ATP+KLA
 NM_017406 cAMP responsive element binding protein-like 1 (Crebl1), mRNA [NM_017406] KLA 1.22 1.30 1.32 1.34 1.51 1.52 1.75
ATP 1.13 1.32 1.16 1.66 1.06 .93 1.54
KLA/ATP 1.37 1.25 1.21 1.74 1.04 1.01 2.07
Cryaa
KLA  ATP  ATP+KLA
 NM_013501 crystallin, alpha A (Cryaa), mRNA [NM_013501] KLA .98 1.04 1.01 1.05 1.00 1.05 1.02
ATP 1.02 .93 .99 1.08 1.03 .99 1.03
KLA/ATP 1.04 1.01 .97 1.01 1.08 1.06 1.03
Cryab
KLA  ATP  ATP+KLA
 NM_009964 crystallin, alpha B (Cryab), mRNA [NM_009964] KLA 1.02 1.08 1.07 1.05 1.05 1.00 1.04
ATP 1.02 1.06 1.05 1.07 1.01 1.01 1.16
KLA/ATP 1.04 1.10 1.13 1.09 .94 .97 1.08
Cul1
KLA  ATP  ATP+KLA
 NM_012042 cullin 1 (Cul1), mRNA [NM_012042] KLA 1.54 1.57 1.59 1.36 1.13 1.06 1.15
ATP 1.02 1.15 1.00 1.02 1.00 1.16 1.10
KLA/ATP 1.54 1.68 1.30 1.46 .98 1.02 1.12
Ddit3
KLA  ATP  ATP+KLA
 NM_007837 DNA-damage inducible transcript 3 (Ddit3), mRNA [NM_007837] KLA .61 .59 .70 1.06 1.69 2.77 3.31
ATP .87 .65 .80 1.34 1.88 1.58 4.98
KLA/ATP .58 .51 .67 1.54 4.63 3.78 8.88
Ddost
KLA  ATP  ATP+KLA
 NM_007838 dolichyl-di-phosphooligosaccharide-protein glycotransferase (Ddost), mRNA [NM_007838] KLA .88 .99 1.00 .83 .86 .92 .96
ATP 1.11 1.34 1.05 1.20 .91 .83 .87
KLA/ATP 1.07 1.01 .77 1.11 .66 .79 .82
Derl1
KLA  ATP  ATP+KLA
 NM_024207 Der1-like domain family, member 1 (Derl1), mRNA [NM_024207] KLA .86 .83 .81 .86 .93 1.11 1.45
ATP 1.06 1.09 1.13 1.07 1.09 1.24 1.72
KLA/ATP .80 .82 .92 .87 .89 1.15 1.99
Derl2
KLA  ATP  ATP+KLA
 NM_033562 Der1-like domain family, member 2 (Derl2), mRNA [NM_033562] KLA .79 .75 .74 .85 .99 1.13 1.20
ATP .90 .80 .92 .69 .67 .85 1.05
KLA/ATP .68 .66 .74 .56 .71 .79 1.10
Derl3
KLA  ATP  ATP+KLA
 NM_024440 Der1-like domain family, member 3 (Derl3), mRNA [NM_024440] KLA .82 .79 .96 .84 .83 .75 .50
ATP 1.05 1.09 .94 .98 .94 .74 .71
KLA/ATP .85 .92 .90 .89 .87 .76 .44
Dnaja1
KLA  ATP  ATP+KLA
 NM_008298 DnaJ (Hsp40) homolog, subfamily A, member 1 (Dnaja1), mRNA [NM_008298] KLA 2.50 2.58 2.81 2.87 2.89 2.98 1.76
ATP .94 .88 1.05 .98 1.05 1.26 1.24
KLA/ATP 2.44 2.48 3.07 2.49 2.22 1.85 1.41
Dnaja2
KLA  ATP  ATP+KLA
 NM_019794 DnaJ (Hsp40) homolog, subfamily A, member 2 (Dnaja2), mRNA [NM_019794] KLA 3.74 4.11 4.59 3.88 3.14 1.56 1.29
ATP .97 1.13 1.30 2.06 2.30 1.84 1.02
KLA/ATP 3.87 4.14 4.00 6.12 4.05 2.60 1.12
Dnajb1
KLA  ATP  ATP+KLA
 NM_018808 DnaJ (Hsp40) homolog, subfamily B, member 1 (Dnajb1), mRNA [NM_018808] KLA .82 .80 1.05 1.23 1.58 1.83 1.25
ATP 1.06 1.05 3.81 13.63 10.70 3.38 1.07
KLA/ATP .83 .91 3.21 10.03 12.53 5.11 1.86
Dnajb10
KLA  ATP  ATP+KLA
 NM_020266 DnaJ (Hsp40) homolog, subfamily B, member 10 (Dnajb10), transcript variant 1, mRNA [NM_020266] KLA 1.42 1.46 1.17 1.08 1.37 1.54 1.66
ATP .93 .90 .85 1.20 1.82 2.59 1.82
KLA/ATP 1.43 1.60 1.25 1.22 1.30 1.93 2.07
Dnajb12
KLA  ATP  ATP+KLA
 AK089427 B6-derived CD11 +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F730027B10 product:DnaJ (Hsp40) homolog, subfamily B, member 12, full insert sequence [AK089427] KLA 1.24 1.12 1.09 1.20 1.08 1.13 1.07
ATP 1.02 1.00 1.23 1.23 1.31 2.55 1.01
KLA/ATP 1.07 1.15 1.32 1.34 1.41 2.21 1.49
Dnajb12
KLA  ATP  ATP+KLA
 NM_019965 DnaJ (Hsp40) homolog, subfamily B, member 12 (Dnajb12), mRNA [NM_019965] KLA 1.05 1.10 1.18 1.23 1.31 1.23 1.26
ATP .90 .96 1.00 1.11 1.00 .98 1.06
KLA/ATP 1.09 1.11 1.24 1.25 1.08 .95 1.05
Dnajc1
KLA  ATP  ATP+KLA
 AK014639 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4733401K02 product:unclassifiable, full insert sequence [AK014639] KLA .94 .95 .99 .87 .93 .94 1.56
ATP 1.01 1.13 .97 .97 .82 .71 .64
KLA/ATP .99 1.06 .87 .85 .68 .65 .84
Dnajc1
KLA  ATP  ATP+KLA
 NM_007869 DnaJ (Hsp40) homolog, subfamily C, member 1 (Dnajc1), mRNA [NM_007869] KLA 1.58 1.51 1.50 1.61 1.49 1.65 2.70
ATP 1.01 .99 .97 1.00 .98 1.32 1.58
KLA/ATP 1.38 1.64 1.84 1.52 1.35 1.04 2.97
Dnajc10
KLA  ATP  ATP+KLA
 NM_024181 DnaJ (Hsp40) homolog, subfamily C, member 10 (Dnajc10), mRNA [NM_024181] KLA .99 1.04 .96 .85 .79 .77 .86
ATP .97 1.05 .96 .90 .71 .73 .89
KLA/ATP .98 1.03 .87 .90 .61 .59 .71
Dnajc3a
KLA  ATP  ATP+KLA
 NM_008929 DnaJ (Hsp40) homolog, subfamily C, member 3A (Dnajc3a), mRNA [NM_008929] KLA .94 .98 .88 .87 .76 .75 .96
ATP 1.00 1.01 1.13 1.09 1.05 1.15 1.58
KLA/ATP .95 .97 1.06 .99 .87 .87 .93
Dnajc5
KLA  ATP  ATP+KLA
 AK035288 adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530010F14 product:unclassifiable, full insert sequence. [AK035288] KLA .81 .84 .93 .88 .93 1.24 1.32
ATP 1.03 1.13 .99 .87 1.10 1.29 1.11
KLA/ATP .90 .90 .76 .68 1.00 1.28 1.36
Dnajc5
KLA  ATP  ATP+KLA
 NM_016775 DnaJ (Hsp40) homolog, subfamily C, member 5 (Dnajc5), mRNA [NM_016775] KLA 1.13 1.08 1.07 1.10 1.27 1.40 1.54
ATP 1.10 1.11 .97 1.07 1.28 1.71 1.90
KLA/ATP 1.11 1.16 .98 1.16 1.12 1.74 2.89
Dnajc5b
KLA  ATP  ATP+KLA
 NM_025489 DnaJ (Hsp40) homolog, subfamily C, member 5 beta (Dnajc5b), mRNA [NM_025489] KLA 1.07 .99 1.02 1.03 .99 1.01 1.02
ATP 1.00 1.00 .98 .95 .98 1.00 1.02
KLA/ATP 1.01 1.04 1.00 .94 .98 .98 1.02
Dnajc5g
KLA  ATP  ATP+KLA
 NM_177677 DnaJ (Hsp40) homolog, subfamily C, member 5 gamma (Dnajc5g), mRNA [NM_177677] KLA 1.00 .95 .98 1.01 .98 .98 1.01
ATP 1.02 .95 1.00 .95 1.01 .94 1.00
KLA/ATP 1.02 1.00 1.01 1.03 .97 .97 1.00
Edem1
KLA  ATP  ATP+KLA
 NM_138677 ER degradation enhancer, mannosidase alpha-like 1 (Edem1), mRNA [NM_138677] KLA .93 .94 .96 .77 .70 .62 .81
ATP 1.02 1.12 .97 .99 .76 .52 .96
KLA/ATP .97 .98 .76 .83 .61 .52 .89
Edem2
KLA  ATP  ATP+KLA
 AK040560 0 day neonate thymus cDNA, RIKEN full-length enriched library, clone:A430106J18 product:unclassifiable, full insert sequence. [AK040560] KLA .97 1.03 1.00 1.02 .99 .97 .95
ATP 1.00 .94 .90 .91 .95 1.00 .98
KLA/ATP 1.09 .97 .95 1.02 1.04 1.03 1.02
Edem2
KLA  ATP  ATP+KLA
 NM_145537 ER degradation enhancer, mannosidase alpha-like 2 (Edem2), mRNA [NM_145537] KLA 1.04 1.16 1.22 1.26 1.48 1.44 1.35
ATP .99 1.13 1.00 1.34 1.10 1.56 2.19
KLA/ATP 1.10 1.19 1.10 1.53 1.33 2.41 3.20
Edem3
KLA  ATP  ATP+KLA
 NM_001039644 ER degradation enhancer, mannosidase alpha-like 3 (Edem3), mRNA [NM_001039644] KLA 1.09 1.02 .97 .82 .66 .70 .84
ATP .90 .89 .84 .70 .96 1.39 .96
KLA/ATP .98 .91 .93 .75 1.03 1.58 .96
Eif2ak1
KLA  ATP  ATP+KLA
 AK032508 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430574E03 product:EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 (EC 2.7.1.-) (HEME-REGULATED EUKARYOTIC INITIATION FACTOR EIF-2-ALPHA KINASE) (HEME-R KLA .65 .66 .65 .67 .67 .85 1.06
ATP 1.07 1.13 1.10 1.03 .70 .63 .72
KLA/ATP .68 .73 .70 .67 .65 .66 .47
Eif2ak1
KLA  ATP  ATP+KLA
 NM_013557 eukaryotic translation initiation factor 2 alpha kinase 1 (Eif2ak1), mRNA [NM_013557] KLA 1.16 1.19 1.32 1.21 1.58 1.51 1.59
ATP 1.19 1.27 .93 1.28 1.02 1.53 1.60
KLA/ATP 1.36 1.50 1.16 1.38 1.12 1.79 2.42
Eif2ak2
KLA  ATP  ATP+KLA
 NM_011163 eukaryotic translation initiation factor 2-alpha kinase 2 (Eif2ak2), mRNA [NM_011163] KLA 6.20 6.38 6.31 6.36 4.86 4.86 2.93
ATP 1.03 .78 .68 .37 .49 3.38 1.97
KLA/ATP 6.50 5.52 5.25 2.87 3.90 4.33 3.35
Eif2ak3
KLA  ATP  ATP+KLA
 AK041698 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630030N06 product:unclassifiable, full insert sequence. [AK041698] KLA .79 .77 .83 .80 .93 .87 .85
ATP .82 .82 .82 .92 .88 .85 .91
KLA/ATP .77 .76 .78 .80 .84 .86 .81
Eif2ak3
KLA  ATP  ATP+KLA
 NM_010121 eukaryotic translation initiation factor 2 alpha kinase 3 (Eif2ak3), mRNA [NM_010121] KLA .28 .28 .27 .29 .38 .36 .47
ATP 1.17 1.04 .62 .48 .54 .48 .67
KLA/ATP .29 .30 .26 .26 .34 .37 .32
Eif2ak4
KLA  ATP  ATP+KLA
 AF193344 GCN2gamma mRNA, complete cds [AF193344] KLA .78 .78 .66 .72 .79 .83 1.05
ATP .97 1.06 .97 .97 .98 .86 .94
KLA/ATP .81 .73 .62 .84 .81 .88 .90
Eif2ak4
KLA  ATP  ATP+KLA
 NM_013719 eukaryotic translation initiation factor 2 alpha kinase 4 (Eif2ak4), mRNA [NM_013719] KLA .60 .55 .49 .54 .59 .67 .91
ATP 1.11 1.18 1.00 .94 1.33 .90 .98
KLA/ATP .59 .54 .56 .58 .90 .86 .86
Eif2s1
KLA  ATP  ATP+KLA
 NM_026114 eukaryotic translation initiation factor 2, subunit 1 alpha (Eif2s1), mRNA [NM_026114] KLA 1.50 1.49 1.52 1.49 1.24 1.12 1.25
ATP 1.00 .98 1.16 1.05 1.03 1.10 .99
KLA/ATP 1.50 1.54 1.73 1.39 1.24 .87 .66
Ern1
KLA  ATP  ATP+KLA
 NM_023913 endoplasmic reticulum (ER) to nucleus signalling 1 (Ern1), mRNA [NM_023913] KLA .92 .92 .88 .96 1.03 1.44 1.49
ATP .86 .90 1.08 2.24 3.28 2.79 2.27
KLA/ATP .91 .86 .95 1.30 2.01 2.03 2.86
Ero1l
KLA  ATP  ATP+KLA
 NM_015774 ERO1-like (S. cerevisiae) (Ero1l), mRNA [NM_015774] KLA 1.52 1.69 1.58 1.47 1.35 1.29 2.08
ATP 1.05 1.16 1.22 1.46 2.06 3.45 3.36
KLA/ATP 1.63 1.78 1.63 1.81 1.38 1.49 3.73
Ero1lb
KLA  ATP  ATP+KLA
 AK004981 adult male liver cDNA, RIKEN full-length enriched library, clone:1300013B24 product:ENDOPLASMIC RETICULUM OXIDOREDUCTIN 1-LBETA homolog [Homo sapiens], full insert sequence. [AK004981] KLA .92 .89 .85 .94 .91 .94 .92
ATP .97 .95 .94 1.26 1.26 .92 .89
KLA/ATP 1.03 .85 .83 .94 1.05 .91 .93
Ero1lb
KLA  ATP  ATP+KLA
 NM_026184 ERO1-like beta (S. cerevisiae) (Ero1lb), mRNA [NM_026184] KLA .85 .88 .88 .75 .71 .64 .70
ATP 1.09 1.08 1.04 1.10 1.12 1.26 1.27
KLA/ATP .92 .94 .87 1.00 1.04 1.20 1.18
Erp29
KLA  ATP  ATP+KLA
 NM_026129 endoplasmic reticulum protein 29 (Erp29), mRNA [NM_026129] KLA .54 .54 .49 .50 .48 .65 .84
ATP .91 .90 .95 .79 .68 .46 .75
KLA/ATP .49 .48 .56 .46 .48 .43 .53
Fbxo2
KLA  ATP  ATP+KLA
 NM_176848 F-box protein 2 (Fbxo2), mRNA [NM_176848] KLA 1.36 1.39 1.42 1.50 1.44 1.56 1.37
ATP 1.03 1.06 1.23 1.30 1.33 1.32 1.17
KLA/ATP 1.41 1.50 1.80 1.69 1.77 1.57 1.51
Fbxo6
KLA  ATP  ATP+KLA
 NM_015797 F-box protein 6 (Fbxo6), mRNA [NM_015797] KLA 1.46 1.48 1.52 1.64 1.57 1.61 1.65
ATP .92 .97 1.02 1.03 .73 .81 1.67
KLA/ATP 1.33 1.45 1.54 1.56 1.25 1.10 2.48
Ganab
KLA  ATP  ATP+KLA
 NM_008060 alpha glucosidase 2 alpha neutral subunit (Ganab), mRNA [NM_008060] KLA .91 .99 .97 .88 .86 .84 .88
ATP 1.01 1.20 .99 1.02 .77 .70 .76
KLA/ATP 1.02 1.10 .90 .85 .66 .66 .77
Gcs1
KLA  ATP  ATP+KLA
 NM_020619 glucosidase 1 (Gcs1), mRNA [NM_020619] KLA .62 .60 .59 .54 .50 .56 .95
ATP .95 .96 1.04 .81 .62 .68 1.23
KLA/ATP .63 .61 .68 .53 .46 .42 .60
H47
KLA  ATP  ATP+KLA
 NM_024439 histocompatibility 47 (H47), mRNA [NM_024439] KLA .93 .93 .99 .99 1.29 1.39 1.35
ATP 1.09 1.04 1.13 1.12 1.25 1.14 1.20
KLA/ATP 1.03 .99 1.18 1.04 1.18 1.14 .85
Herpud1
KLA  ATP  ATP+KLA
 NM_022331 homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 (Herpud1), mRNA [NM_022331] KLA .60 .57 .52 .94 1.60 .84 .84
ATP .98 .92 1.07 1.55 4.38 .67 .72
KLA/ATP .52 .54 .50 .76 1.99 .55 .33
Hsp90aa1
KLA  ATP  ATP+KLA
 NM_010480 heat shock protein 90, alpha (cytosolic), class A member 1 (Hsp90aa1), mRNA [NM_010480] KLA .95 1.03 .90 .92 .80 .94 .99
ATP .96 .92 1.39 1.21 2.02 3.66 1.10
KLA/ATP .93 .92 1.32 1.01 1.85 2.21 1.20
Hsp90ab1
KLA  ATP  ATP+KLA
 NM_008302 heat shock protein 90kDa alpha (cytosolic), class B member 1 (Hsp90ab1), mRNA [NM_008302] KLA .93 1.02 .98 .82 .95 1.10 1.39
ATP 1.04 1.14 .92 1.32 1.19 1.02 .63
KLA/ATP 1.02 1.04 .80 1.12 .87 .86 .75
Hsp90b1
KLA  ATP  ATP+KLA
 NM_011631 heat shock protein 90, beta (Grp94), member 1 (Hsp90b1), mRNA [NM_011631] KLA .78 .83 .71 .69 .73 .69 .80
ATP 1.00 1.08 1.01 .94 .84 .84 .66
KLA/ATP .78 .82 .81 .73 .66 .68 .27
Hspa1a
KLA  ATP  ATP+KLA
 NM_010479 heat shock protein 1A (Hspa1a), mRNA [NM_010479] KLA 7.88 6.99 4.47 5.18 7.81 11.47 4.14
ATP 1.88 5.62 43.42 58.76 55.53 28.89 9.13
KLA/ATP 7.40 7.62 28.23 54.12 70.14 43.09 22.49
Hspa1b
KLA  ATP  ATP+KLA
 NM_010478 heat shock protein 1B (Hspa1b), mRNA [NM_010478] KLA 5.01 4.73 3.77 3.62 4.81 6.53 3.12
ATP 1.34 3.07 14.11 17.14 17.51 11.21 4.82
KLA/ATP 5.04 5.15 11.63 19.94 20.84 15.79 9.30
Hspa1l
KLA  ATP  ATP+KLA
 NM_013558 heat shock protein 1-like (Hspa1l), mRNA [NM_013558] KLA .98 1.04 1.10 1.21 1.51 1.97 1.86
ATP 1.03 1.08 1.07 1.14 .93 1.21 1.89
KLA/ATP 1.06 1.01 .99 1.09 .97 1.39 2.87
Hspa2
KLA  ATP  ATP+KLA
 NM_008301 heat shock protein 2 (Hspa2), transcript variant 1, mRNA [NM_008301] KLA .98 .97 1.12 1.23 1.20 1.72 1.38
ATP 1.01 1.10 1.45 3.12 2.45 1.98 .98
KLA/ATP .99 1.12 1.52 2.60 2.89 2.62 1.18
Hspa4l
KLA  ATP  ATP+KLA
 NM_011020 heat shock protein 4 like (Hspa4l), mRNA [NM_011020] KLA 1.77 1.68 2.01 1.89 1.22 .93 .93
ATP 1.04 .95 1.27 1.07 1.30 3.95 1.95
KLA/ATP 1.73 1.65 2.01 1.55 1.64 2.68 2.16
Hspa5
KLA  ATP  ATP+KLA
 NM_022310 heat shock protein 5 (Hspa5), mRNA [NM_022310] KLA 1.58 1.55 1.47 1.58 1.81 1.30 1.22
ATP 1.10 1.23 1.04 1.19 1.61 1.72 1.20
KLA/ATP 1.80 1.85 1.54 1.66 1.67 1.80 .93
Hspa8
KLA  ATP  ATP+KLA
 NM_031165 heat shock protein 8 (Hspa8), mRNA [NM_031165] KLA 1.00 .98 1.27 1.18 1.45 1.60 1.31
ATP 1.22 1.18 1.07 1.44 1.07 .53 .57
KLA/ATP 1.18 1.22 1.14 1.08 .93 .82 .77
Hsph1
KLA  ATP  ATP+KLA
 NM_013559 heat shock 105kDa/110kDa protein 1 (Hsph1), mRNA [NM_013559] KLA .54 .53 .48 .44 .38 .91 1.26
ATP 1.07 1.00 1.46 1.34 1.81 2.66 1.72
KLA/ATP .57 .54 .73 .59 .82 1.82 1.95
Hyou1
KLA  ATP  ATP+KLA
 BC019785 hypoxia up-regulated 1, mRNA (cDNA clone MGC:30561 IMAGE:5151731), complete cds. [BC019785] KLA .75 .77 .78 .79 .87 .78 .94
ATP .84 .73 .73 .77 .99 .81 .99
KLA/ATP .78 .74 .72 .74 .85 .81 .76
Hyou1
KLA  ATP  ATP+KLA
 NM_021395 hypoxia up-regulated 1 (Hyou1), mRNA [NM_021395] KLA 1.12 1.19 .97 1.01 .88 .83 1.03
ATP .94 1.01 1.09 .98 .88 .94 .95
KLA/ATP 1.01 1.11 1.16 1.02 .75 .68 .52
LOC10004
7481
KLA  ATP  ATP+KLA
 XM_001478242 ref|PREDICTED: Mus musculus similar to SEC24 related gene family, member B (S. cerevisiae) (LOC100047481), mRNA [XM_001478242] KLA 5.55 4.84 5.37 4.81 2.08 1.41 .97
ATP .90 .86 1.24 .86 .75 1.32 .69
KLA/ATP 4.42 5.04 6.38 4.25 2.21 1.58 1.05
Lman1
KLA  ATP  ATP+KLA
 AK011495 10 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2610020P13 product:lectin, mannose-binding, 1, full insert sequence. [AK011495] KLA 1.67 1.55 1.58 1.63 1.52 1.49 2.27
ATP 1.09 1.10 1.37 1.37 1.25 1.85 2.17
KLA/ATP 1.55 1.43 2.23 1.78 1.50 1.51 1.95
Lman1
KLA  ATP  ATP+KLA
 NM_027400 lectin, mannose-binding, 1 (Lman1), mRNA [NM_027400] KLA .88 .85 .71 .69 .56 .59 .89
ATP .94 .93 1.16 .87 .84 .72 .65
KLA/ATP .75 .78 .91 .65 .64 .57 .32
Lman1l
KLA  ATP  ATP+KLA
 NM_199222 lectin, mannose-binding 1 like (Lman1l), mRNA [NM_199222] KLA 1.07 1.09 1.13 1.10 1.08 1.04 1.05
ATP .99 .99 1.04 1.22 1.68 1.82 1.12
KLA/ATP 1.17 1.17 1.17 1.37 4.23 5.51 1.41
Lman2
KLA  ATP  ATP+KLA
 NM_025828 lectin, mannose-binding 2 (Lman2), mRNA [NM_025828] KLA .75 .74 .70 .63 .70 .58 .51
ATP 1.28 1.38 .84 1.02 .89 .56 .53
KLA/ATP .82 .87 .64 .82 .62 .54 .30
Man1a
KLA  ATP  ATP+KLA
 NM_008548 mannosidase 1, alpha (Man1a), mRNA [NM_008548] KLA 1.15 1.18 1.19 .93 .66 .37 .35
ATP 1.09 1.21 1.08 1.89 1.20 1.15 .63
KLA/ATP 1.15 1.25 1.02 1.36 .83 .61 .35
Man1a2
KLA  ATP  ATP+KLA
 AK078291 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430575L20 product:unclassifiable, full insert sequence [AK078291] KLA 1.27 1.23 1.12 .98 .77 .89 .85
ATP .97 1.03 1.00 .87 .74 1.09 1.05
KLA/ATP 1.19 1.20 1.11 1.02 .89 .94 .93
Man1a2
KLA  ATP  ATP+KLA
 NM_010763 mannosidase, alpha, class 1A, member 2 (Man1a2), mRNA [NM_010763] KLA 1.36 1.42 1.22 1.13 .86 1.12 1.12
ATP .93 .98 .95 .76 .75 1.51 1.47
KLA/ATP 1.34 1.39 1.25 1.15 1.09 1.21 1.55
Man1b1
KLA  ATP  ATP+KLA
 NM_001029983 mannosidase, alpha, class 1B, member 1 (Man1b1), mRNA [NM_001029983] KLA .72 .76 .73 .68 .84 .77 .93
ATP .99 .79 .31 .46 .75 .75 1.03
KLA/ATP .81 .58 .25 .36 .57 .55 .92
Man1c1
KLA  ATP  ATP+KLA
 NM_207237 mannosidase, alpha, class 1C, member 1 (Man1c1), mRNA [NM_207237] KLA .46 .43 .41 .30 .26 .43 .44
ATP 1.03 1.12 .85 .98 .61 .35 .76
KLA/ATP .48 .44 .32 .34 .33 .43 .34
Map2k7
KLA  ATP  ATP+KLA
 BC070467 mitogen activated protein kinase kinase 7, mRNA (cDNA clone MGC:96654 IMAGE:30615302), complete cds [BC070467] KLA .77 .79 .88 .77 .97 .96 1.27
ATP 1.11 1.26 .93 1.19 1.13 1.45 1.16
KLA/ATP .89 .88 .59 .89 .86 1.32 1.28
Map2k7
KLA  ATP  ATP+KLA
 NM_001042557 mitogen-activated protein kinase kinase 7 (Map2k7), transcript variant 1, mRNA [NM_001042557] KLA .96 .95 1.02 .96 .95 1.09 1.19
ATP 1.02 1.07 .88 .97 .93 1.10 1.17
KLA/ATP 1.01 .99 .80 .87 .76 1.21 1.16
Map3k5
KLA  ATP  ATP+KLA
 NM_008580 mitogen-activated protein kinase kinase kinase 5 (Map3k5), mRNA [NM_008580] KLA 1.85 1.97 1.17 .82 .57 .47 .49
ATP 1.06 1.05 .94 1.22 1.55 .91 .32
KLA/ATP 2.00 1.82 .95 .91 .60 .34 .28
Mapk10
KLA  ATP  ATP+KLA
 AK076990 adult male testis cDNA, RIKEN full-length enriched library, clone:4930597C01 product:mitogen activated protein kinase 10, full insert sequence. [AK076990] KLA 1.03 1.05 .98 1.04 .94 .95 1.02
ATP 1.00 .99 1.06 .97 1.01 .96 .99
KLA/ATP 1.07 1.01 .95 1.05 .82 .95 .87
Mapk10
KLA  ATP  ATP+KLA
 NM_009158 mitogen-activated protein kinase 10 (Mapk10), transcript variant 1, mRNA [NM_009158] KLA .95 1.00 .97 1.01 .99 1.01 .95
ATP 1.01 1.02 .98 1.01 1.04 1.01 .99
KLA/ATP 1.05 .99 1.01 .98 .92 .97 .98
Mapk8
KLA  ATP  ATP+KLA
 AK162915 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330031O19 product:mitogen activated protein kinase 8, full insert sequence [AK162915] KLA .94 .86 .80 .83 .77 .85 .83
ATP 1.08 1.12 .94 .80 .83 .71 .75
KLA/ATP .83 .81 .80 .74 .74 .75 .67
Mapk8
KLA  ATP  ATP+KLA
 AK163829 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130070A06 product:mitogen activated protein kinase 8, full insert sequence [AK163829] KLA .65 .61 .66 .70 .90 1.02 1.03
ATP .99 .94 1.68 1.44 1.75 1.84 1.10
KLA/ATP .63 .67 1.11 1.00 2.01 1.68 1.15
Mapk8
KLA  ATP  ATP+KLA
 NM_016700 mitogen-activated protein kinase 8 (Mapk8), mRNA [NM_016700] KLA .96 1.00 .94 .96 .94 .99 1.04
ATP 1.01 1.05 1.01 .99 1.03 .98 1.02
KLA/ATP .96 .97 .96 .97 .93 .94 .96
Mapk9
KLA  ATP  ATP+KLA
 NM_016961 mitogen-activated protein kinase 9 (Mapk9), transcript variant 2, mRNA [NM_016961] KLA 1.28 1.37 1.59 1.60 1.61 1.43 1.38
ATP 1.03 .99 .74 .71 .79 1.20 1.01
KLA/ATP 1.53 1.30 1.07 .99 .83 1.10 1.40
Mapk9
KLA  ATP  ATP+KLA
 NM_207692 mitogen-activated protein kinase 9 (Mapk9), transcript variant 1, mRNA [NM_207692] KLA 1.39 1.53 1.69 1.69 1.55 1.44 1.51
ATP .95 .92 .75 .85 .70 1.46 1.17
KLA/ATP 1.37 1.35 .99 1.18 .91 1.22 1.62
Mbtps1
KLA  ATP  ATP+KLA
 NM_019709 membrane-bound transcription factor peptidase, site 1 (Mbtps1), mRNA [NM_019709] KLA .78 .75 .75 .68 .59 .56 .65
ATP .98 .94 .90 .66 .75 .78 .98
KLA/ATP .77 .74 .67 .54 .61 .62 .56
Mbtps2
KLA  ATP  ATP+KLA
 NM_172307 membrane-bound transcription factor peptidase, site 2 (Mbtps2), mRNA [NM_172307] KLA .93 .91 .96 1.04 1.03 .99 1.08
ATP .94 .91 1.08 1.03 .95 .99 1.22
KLA/ATP .92 .96 .93 .91 .85 .88 .97
Mm.12616
KLA  ATP  ATP+KLA
 31542562 Unknown KLA 1.02 1.06 .92 .95 .78 .75 .71
ATP 1.02 1.12 1.35 1.01 .89 .77 .89
KLA/ATP 1.13 1.09 1.10 1.00 .70 .57 .44
Mm.18854
4
KLA  ATP  ATP+KLA
 141802696 Unknown KLA .76 .82 .79 .80 .80 .91 .98
ATP .92 .91 1.08 .88 .83 .86 .80
KLA/ATP .73 .82 .86 .84 .85 .83 .66
Mm.31903
8
KLA  ATP  ATP+KLA
 164518941 Unknown KLA .91 .84 .91 .94 .91 .78 .81
ATP 1.19 1.28 1.04 1.53 1.42 1.10 1.11
KLA/ATP 1.08 1.05 1.00 1.43 1.04 .92 .81
Mm.32987
3
KLA  ATP  ATP+KLA
 133504850 Unknown KLA .89 .87 .88 .81 .90 .98 .97
ATP 1.02 1.03 .92 .78 .87 .95 1.16
KLA/ATP .88 .87 .90 .76 .90 .94 1.18
Mm.37167
3
KLA  ATP  ATP+KLA
 85662412 Unknown KLA 1.10 1.15 1.02 1.11 1.26 1.04 1.07
ATP 1.02 1.06 1.17 1.13 1.08 .92 1.10
KLA/ATP 1.04 1.08 1.27 1.14 1.12 1.07 1.11
Mm.37899
0
KLA  ATP  ATP+KLA
 144227203 Unknown KLA 5.51 4.67 4.55 6.22 4.34 4.26 2.87
ATP 1.00 .76 .68 .41 .53 3.65 1.93
KLA/ATP 4.53 4.63 5.45 2.73 3.51 4.58 3.75
Mm.38868
KLA  ATP  ATP+KLA
 133892179 Unknown KLA .73 .72 .80 .90 1.34 2.01 1.18
ATP .88 .86 1.00 .81 .86 1.07 3.21
KLA/ATP .65 .70 .80 .70 .96 1.68 4.64
Mm.41274
5
KLA  ATP  ATP+KLA
 110681696 Unknown KLA .97 1.07 1.11 1.07 1.38 1.63 1.35
ATP 1.06 1.09 1.05 1.29 1.04 .50 .56
KLA/ATP 1.11 1.12 1.04 1.11 .92 .83 .74
Mm.41947
9
KLA  ATP  ATP+KLA
 118130836 Unknown KLA 1.09 1.14 1.20 .95 1.06 1.08 1.24
ATP 1.11 1.27 1.00 1.39 .89 .83 1.00
KLA/ATP 1.23 1.26 .89 1.44 .86 .76 .90
Mm.42163
KLA  ATP  ATP+KLA
 157951683 Unknown KLA 1.15 1.26 1.21 1.33 1.13 1.06 .99
ATP 1.07 1.05 1.10 1.32 1.03 1.01 1.00
KLA/ATP 1.19 1.16 1.15 1.47 1.11 1.12 .96
Mm.46954
6
KLA  ATP  ATP+KLA
 158749639 Unknown KLA .54 .56 .59 .55 .68 .79 .85
ATP 1.15 1.16 1.22 1.00 1.12 .80 .47
KLA/ATP .65 .64 .68 .72 .72 .59 .45
Mm.6803
KLA  ATP  ATP+KLA
 133893257 Unknown KLA 1.32 1.25 1.08 1.12 1.16 .91 .77
ATP 1.10 1.09 1.11 1.22 1.17 1.01 .69
KLA/ATP 1.13 1.30 1.35 1.44 1.22 1.03 .68
Myd116
KLA  ATP  ATP+KLA
 NM_008654 myeloid differentiation primary response gene 116 (Myd116), mRNA [NM_008654] KLA 3.04 3.52 2.03 1.96 2.40 1.60 2.36
ATP 1.51 2.44 4.23 12.36 8.35 3.80 1.89
KLA/ATP 4.22 5.17 4.76 12.82 10.32 6.20 5.86
Nfe2l2
KLA  ATP  ATP+KLA
 AK029360 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4833405D16 product:nuclear, factor, erythroid derived 2, like 2, full insert sequence. [AK029360] KLA 1.33 1.32 1.54 1.46 1.32 1.26 1.04
ATP 1.18 .93 1.01 1.06 1.47 2.16 1.22
KLA/ATP 1.26 1.25 1.38 1.34 1.26 1.91 1.92
Nfe2l2
KLA  ATP  ATP+KLA
 NM_010902 nuclear factor, erythroid derived 2, like 2 (Nfe2l2), mRNA [NM_010902] KLA .66 .69 .93 .98 1.05 .69 .80
ATP 1.06 1.19 1.92 2.86 3.58 2.71 1.03
KLA/ATP .64 .67 1.31 2.36 2.38 2.06 1.46
Ngly1
KLA  ATP  ATP+KLA
 NM_021504 N-glycanase 1 (Ngly1), mRNA [NM_021504] KLA 1.03 .99 1.03 1.05 1.10 1.18 1.10
ATP .98 .91 1.18 .93 .72 .73 1.00
KLA/ATP .93 1.00 1.06 .95 .76 .66 .84
Nploc4
KLA  ATP  ATP+KLA
 NM_199469 nuclear protein localization 4 homolog (S. cerevisiae) (Nploc4), mRNA [NM_199469] KLA 1.16 1.14 1.14 1.29 1.36 1.33 1.63
ATP 1.05 1.10 .98 .98 1.26 1.80 1.37
KLA/ATP 1.29 1.33 1.14 .92 .92 1.50 1.79
Nsfl1c
KLA  ATP  ATP+KLA
 NM_198326 NSFL1 (p97) cofactor (p47) (Nsfl1c), mRNA [NM_198326] KLA 1.13 1.14 1.11 .96 1.21 1.18 1.23
ATP 1.15 1.21 1.05 1.30 .92 .84 .98
KLA/ATP 1.25 1.25 1.02 1.42 .98 .73 .92
Os9
KLA  ATP  ATP+KLA
 AK014574 0 day neonate skin cDNA, RIKEN full-length enriched library, clone:4632413K17 product:hypothetical protein, full insert sequence. [AK014574] KLA 1.00 1.01 .93 .97 .94 .98 1.04
ATP .95 1.06 1.01 1.03 .99 1.00 .93
KLA/ATP 1.02 .98 .99 1.01 1.06 1.00 1.00
Os9
KLA  ATP  ATP+KLA
 NM_177614 amplified in osteosarcoma (Os9), mRNA [NM_177614] KLA 1.00 1.10 1.03 1.03 1.07 1.13 1.18
ATP 1.02 1.15 1.07 1.32 1.07 .86 1.37
KLA/ATP 1.16 1.16 1.00 1.36 .94 .90 1.38
P4hb
KLA  ATP  ATP+KLA
 NM_011032 prolyl 4-hydroxylase, beta polypeptide (P4hb), mRNA [NM_011032] KLA .70 .77 .78 .67 .70 .70 .99
ATP 1.03 1.03 .95 1.17 1.12 1.13 1.34
KLA/ATP .80 .79 .72 .89 .81 .88 .93
Park2
KLA  ATP  ATP+KLA
 NM_016694 parkin (Park2), mRNA [NM_016694] KLA .95 .95 .94 1.01 .86 .83 .99
ATP .97 .96 1.08 1.03 .85 .70 .74
KLA/ATP .95 .93 1.00 1.01 .86 .69 .77
Pdia3
KLA  ATP  ATP+KLA
 M73329 phospholipase C-alpha (PLC-alpha) mRNA, complete cds. [M73329] KLA .96 .91 .85 .76 .80 .80 1.14
ATP 1.08 1.23 1.01 1.30 .91 .97 .91
KLA/ATP 1.01 1.02 .78 .96 .60 .73 .61
Pdia4
KLA  ATP  ATP+KLA
 NM_009787 protein disulfide isomerase associated 4 (Pdia4), mRNA [NM_009787] KLA 1.00 .91 .96 .78 .79 .72 .84
ATP 1.15 1.31 1.24 1.69 1.03 .66 1.40
KLA/ATP 1.05 1.10 .94 1.43 .77 .65 .69
Pdia6
KLA  ATP  ATP+KLA
 NM_027959 protein disulfide isomerase associated 6 (Pdia6), mRNA [NM_027959] KLA 1.00 .95 .99 .98 .99 .89 1.09
ATP 1.07 1.04 1.08 1.13 1.16 .89 .78
KLA/ATP 1.02 1.06 1.22 1.04 .96 .83 .44
Plaa
KLA  ATP  ATP+KLA
 NM_172695 phospholipase A2, activating protein (Plaa), mRNA [NM_172695] KLA 1.19 1.19 1.15 1.17 1.23 1.41 1.44
ATP .98 1.05 .97 .93 .94 .96 .90
KLA/ATP 1.13 1.18 .97 1.02 .88 .87 .70
Preb
KLA  ATP  ATP+KLA
 NM_016703 prolactin regulatory element binding (Preb), mRNA [NM_016703] KLA .50 .49 .52 .57 .75 .99 1.05
ATP .92 .90 1.11 .91 .77 1.28 1.24
KLA/ATP .49 .48 .62 .50 .59 .92 1.08
Prkcsh
KLA  ATP  ATP+KLA
 NM_008925 protein kinase C substrate 80K-H (Prkcsh), mRNA [NM_008925] KLA .86 .92 .92 .88 1.22 1.43 1.42
ATP 1.03 1.13 .93 1.17 1.03 1.21 1.76
KLA/ATP .96 .95 .72 1.01 .84 1.34 2.32
Rad23a
KLA  ATP  ATP+KLA
 NM_009010 RAD23a homolog (S. cerevisiae) (Rad23a), mRNA [NM_009010] KLA 1.06 1.04 1.05 .99 1.14 1.23 1.52
ATP .98 1.08 .91 1.23 .92 .47 .89
KLA/ATP 1.11 1.18 .91 1.25 .80 .56 .85
Rad23b
KLA  ATP  ATP+KLA
 AK084917 13 days embryo lung cDNA, RIKEN full-length enriched library, clone:D430011I09 product:RAD23b homolog (S. cerevisiae), full insert sequence. [AK084917] KLA .89 .81 .75 .76 .94 .93 .99
ATP 1.04 1.10 1.31 1.52 1.05 .85 .90
KLA/ATP .89 .90 .84 1.02 .82 .83 .89
Rad23b
KLA  ATP  ATP+KLA
 NM_009011 RAD23b homolog (S. cerevisiae) (Rad23b), mRNA [NM_009011] KLA 1.12 1.07 1.06 1.08 .99 1.07 1.24
ATP 1.10 1.19 1.30 1.60 1.65 .87 .68
KLA/ATP 1.26 1.14 1.20 1.35 .99 .68 .45
Rbx1
KLA  ATP  ATP+KLA
 NM_019712 ring-box 1 (Rbx1), mRNA [NM_019712] KLA 1.04 1.01 .98 1.09 1.06 1.14 1.09
ATP .92 .89 1.13 1.16 1.68 1.07 .83
KLA/ATP .99 .99 1.25 1.31 2.63 2.06 .67
Rnf185
KLA  ATP  ATP+KLA
 NM_145355 ring finger protein 185 (Rnf185), mRNA [NM_145355] KLA 1.08 1.12 1.20 1.30 1.42 1.52 1.44
ATP .98 1.10 .92 1.03 2.22 2.31 2.25
KLA/ATP 1.15 1.15 1.03 1.13 1.58 2.13 3.45
Rnf5
KLA  ATP  ATP+KLA
 NM_019403 ring finger protein 5 (Rnf5), mRNA [NM_019403] KLA .86 .81 .86 .77 .87 .79 .86
ATP 1.12 1.18 .92 1.13 .85 .58 1.04
KLA/ATP .87 .95 .85 1.04 .68 .61 .83
Rpn1
KLA  ATP  ATP+KLA
 NM_133933 ribophorin I (Rpn1), mRNA [NM_133933] KLA .79 .80 .74 .71 .66 .66 .86
ATP 1.02 .96 1.08 .94 .93 .86 .96
KLA/ATP .80 .84 .85 .74 .74 .69 .56
Rpn2
KLA  ATP  ATP+KLA
 NM_019642 ribophorin II (Rpn2), mRNA [NM_019642] KLA 1.06 1.03 1.13 .99 1.05 .92 .92
ATP 1.08 1.10 .95 .97 .87 .80 .82
KLA/ATP 1.10 1.10 1.00 1.03 .71 .67 .66
Rrbp1
KLA  ATP  ATP+KLA
 NM_024281 ribosome binding protein 1 (Rrbp1), transcript variant 1, mRNA [NM_024281] KLA 1.65 1.75 1.98 1.95 2.38 2.46 2.23
ATP 1.08 1.08 .91 1.09 1.03 1.25 1.81
KLA/ATP 1.84 1.94 1.85 2.14 1.97 1.98 2.56
Rrbp1
KLA  ATP  ATP+KLA
 NM_133626 ribosome binding protein 1 (Rrbp1), transcript variant 2, mRNA [NM_133626] KLA 1.63 1.74 1.88 1.92 2.29 2.44 2.34
ATP .97 .96 1.13 1.15 .98 1.14 1.83
KLA/ATP 1.60 1.78 2.25 2.44 2.06 1.75 2.02
Sar1a
KLA  ATP  ATP+KLA
 NM_009120 SAR1 gene homolog A (S. cerevisiae) (Sar1a), mRNA [NM_009120] KLA 1.66 1.79 1.74 1.76 1.68 1.55 1.50
ATP 1.00 .92 1.03 1.06 1.54 2.40 2.04
KLA/ATP 1.76 1.85 1.67 1.85 1.98 2.32 3.21
Sar1b
KLA  ATP  ATP+KLA
 NM_025535 SAR1 gene homolog B (S. cerevisiae) (Sar1b), mRNA [NM_025535] KLA 1.22 1.22 1.22 1.25 1.16 1.20 1.31
ATP 1.03 1.07 1.22 1.21 1.20 1.02 1.15
KLA/ATP 1.32 1.17 1.22 1.22 1.15 1.12 1.09
Sec13
KLA  ATP  ATP+KLA
 NM_024206 SEC13 homolog (S. cerevisiae) (Sec13), mRNA [NM_024206] KLA 1.23 1.31 1.29 1.20 1.27 1.27 1.36
ATP 1.00 1.05 1.10 1.27 1.02 .93 1.18
KLA/ATP 1.25 1.37 1.30 1.49 1.10 1.11 .99
Sec23a
KLA  ATP  ATP+KLA
 NM_009147 SEC23A (S. cerevisiae) (Sec23a), mRNA [NM_009147] KLA 1.17 1.25 1.27 1.27 1.19 1.03 1.14
ATP 1.05 1.07 1.17 1.09 .98 1.06 .88
KLA/ATP 1.21 1.27 1.16 1.20 .92 .93 .90
Sec23b
KLA  ATP  ATP+KLA
 NM_019787 SEC23B (S. cerevisiae) (Sec23b), mRNA [NM_019787] KLA 1.80 1.87 2.16 1.95 2.01 1.52 1.32
ATP 1.09 1.13 1.05 1.09 1.06 1.48 1.32
KLA/ATP 1.90 1.96 1.92 1.90 1.75 1.81 1.44
Sec24a
KLA  ATP  ATP+KLA
 AK031553 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030450O12 product:similar to PROTEIN TRANSPORT PROTEIN SEC24A (SEC24-RELATED PROTEIN A) (FRAGMENT) [Homo sapiens], full insert sequence. [AK031553] KLA 1.03 .85 .78 .89 .99 .81 1.03
ATP .93 .97 1.41 1.81 1.11 .94 1.04
KLA/ATP .90 .82 .89 .99 1.00 .95 .85
Sec24a
KLA  ATP  ATP+KLA
 NM_175255 SEC24 related gene family, member A (S. cerevisiae) (Sec24a), mRNA [NM_175255] KLA 1.37 1.25 1.19 1.06 .98 .94 1.31
ATP 1.11 1.20 1.43 3.89 2.89 1.70 1.64
KLA/ATP 1.41 1.39 1.31 1.62 1.60 1.46 1.47
Sec24b
KLA  ATP  ATP+KLA
 NM_207209 SEC24 related gene family, member B (S. cerevisiae) (Sec24b), mRNA [NM_207209] KLA 5.10 5.15 4.97 3.81 2.07 1.37 1.08
ATP 1.07 1.23 1.24 1.13 1.05 1.68 1.01
KLA/ATP 4.94 4.72 5.11 4.98 2.54 2.37 2.16
Sec24c
KLA  ATP  ATP+KLA
 NM_172596 SEC24 related gene family, member C (S. cerevisiae) (Sec24c), mRNA [NM_172596] KLA .96 .95 1.01 .93 1.07 .99 1.12
ATP 1.04 1.07 .79 .79 .66 .81 1.20
KLA/ATP 1.03 .98 .69 .77 .61 .79 1.15
Sec24d
KLA  ATP  ATP+KLA
 NM_027135 SEC24 related gene family, member D (S. cerevisiae) (Sec24d), mRNA [NM_027135] KLA .79 .74 .65 .56 .68 .95 .97
ATP 1.13 1.25 1.23 1.04 .72 .93 1.08
KLA/ATP .81 .78 .77 .78 .57 .82 .74
Sec31a
KLA  ATP  ATP+KLA
 XM_132230 gb|PREDICTED: Mus musculus SEC31 homolog A (S. cerevisiae) (Sec31a), mRNA [XM_132230] KLA .92 .90 .87 .75 .70 .76 1.11
ATP 1.01 1.07 1.05 1.12 .85 .85 .95
KLA/ATP .91 .88 .76 .90 .63 .61 .62
Sec31b
KLA  ATP  ATP+KLA
 NM_001033343 Sec31 homolog B (S. cerevisiae) (Sec31b), mRNA [NM_001033343] KLA .92 .91 .94 .92 .94 .93 .99
ATP 1.01 1.00 1.02 .88 .87 .91 1.05
KLA/ATP .88 .94 .98 .82 .88 .91 1.08
Sec61a1
KLA  ATP  ATP+KLA
 NM_016906 Sec61 alpha 1 subunit (S. cerevisiae) (Sec61a1), mRNA [NM_016906] KLA .97 .99 .99 1.04 1.05 1.07 1.21
ATP 1.03 1.02 .87 .94 .94 .96 1.23
KLA/ATP .98 .99 .90 .96 .77 .89 1.02
Sec61a2
KLA  ATP  ATP+KLA
 NM_021305 Sec61, alpha subunit 2 (S. cerevisiae) (Sec61a2), mRNA [NM_021305] KLA .86 .92 .91 .78 .84 .85 1.21
ATP 1.05 1.08 .72 .79 1.33 .93 1.13
KLA/ATP .91 .92 .68 .79 .88 1.03 1.02
Sec61b
KLA  ATP  ATP+KLA
 NM_024171 Sec61 beta subunit (Sec61b), mRNA [NM_024171] KLA .95 .88 .80 .87 .74 .76 .93
ATP .93 .97 1.17 1.20 1.01 .84 .89
KLA/ATP .81 .89 1.04 .99 1.00 .82 .56
Sec61g
KLA  ATP  ATP+KLA
 NM_011343 SEC61, gamma subunit (Sec61g), transcript variant 1, mRNA [NM_011343] KLA 1.19 1.06 1.12 1.34 1.13 1.11 1.10
ATP 1.09 .98 1.22 1.13 1.22 1.39 1.01
KLA/ATP 1.16 1.19 1.63 1.25 1.58 1.41 .96
Sec63
KLA  ATP  ATP+KLA
 NM_153055 SEC63-like (S. cerevisiae) (Sec63), mRNA [NM_153055] KLA 1.08 1.10 1.04 .98 .87 .78 .72
ATP 1.02 .95 1.00 .87 .90 .81 .72
KLA/ATP 1.01 1.11 1.17 .99 .85 .67 .48
Sel1l
KLA  ATP  ATP+KLA
 NM_001039089 sel-1 suppressor of lin-12-like (C. elegans) (Sel1l), transcript variant 1, mRNA [NM_001039089] KLA 1.44 1.40 1.48 1.19 1.12 .91 .88
ATP 1.08 1.10 .85 .67 .84 .90 1.06
KLA/ATP 1.50 1.56 1.08 .89 .70 .68 .88
Sil1
KLA  ATP  ATP+KLA
 NM_030749 endoplasmic reticulum chaperone SIL1 homolog (S. cerevisiae) (Sil1), mRNA [NM_030749] KLA .86 .85 .80 .79 .70 .74 .86
ATP .92 .90 1.20 1.08 .90 .73 .76
KLA/ATP .77 .85 1.09 .90 .86 .65 .65
Skp1a
KLA  ATP  ATP+KLA
 NM_011543 S-phase kinase-associated protein 1A (Skp1a), mRNA [NM_011543] KLA 1.05 1.00 .92 .92 .88 .89 1.02
ATP .90 .98 1.21 1.43 1.32 1.46 1.09
KLA/ATP .93 1.01 1.11 1.31 1.21 1.27 1.21
Ssr2
KLA  ATP  ATP+KLA
 NM_025448 signal sequence receptor, beta (Ssr2), mRNA [NM_025448] KLA 1.00 1.04 1.05 .99 1.07 1.17 1.22
ATP .99 1.05 1.04 1.23 1.04 1.11 1.29
KLA/ATP 1.08 1.13 1.12 1.26 1.07 1.28 1.45
Ssr3
KLA  ATP  ATP+KLA
 NM_026155 signal sequence receptor, gamma (Ssr3), mRNA [NM_026155] KLA 1.60 1.71 1.87 1.63 1.72 1.45 1.04
ATP .97 1.05 1.08 1.03 1.04 1.14 1.08
KLA/ATP 1.64 1.67 1.69 1.73 1.40 1.35 1.23
Ssr4
KLA  ATP  ATP+KLA
 NM_009279 signal sequence receptor, delta (Ssr4), mRNA [NM_009279] KLA .90 .95 .95 .93 .86 .86 .98
ATP 1.00 .98 1.04 1.12 .99 .91 1.13
KLA/ATP .96 .99 1.04 1.10 .96 .86 1.06
Stt3a
KLA  ATP  ATP+KLA
 AK030363 adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330402C17 product:OLIGOSACCHARYL TRANSFERASE STT3 SUBUNIT HOMOLOG (B5) (INTEGRAL MEMBRANE PROTEIN 1) homolog [Mus musculus], full insert sequence [AK030363] KLA 1.23 1.24 1.18 1.17 1.00 1.05 1.09
ATP .94 .96 1.28 .97 .87 .70 .70
KLA/ATP 1.13 1.24 1.34 .98 .91 .69 .53
Stt3a
KLA  ATP  ATP+KLA
 NM_008408 STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae) (Stt3a), mRNA [NM_008408] KLA 1.21 1.29 1.21 1.07 1.07 .88 1.08
ATP 1.17 1.46 1.01 1.36 .92 .66 .90
KLA/ATP 1.24 1.45 .82 1.29 .62 .60 .62
Stt3b
KLA  ATP  ATP+KLA
 NM_024222 STT3, subunit of the oligosaccharyltransferase complex, homolog B (S. cerevisiae) (Stt3b), mRNA [NM_024222] KLA .99 1.02 .94 .82 .70 .57 .92
ATP 1.11 1.19 .92 1.18 1.01 .82 1.06
KLA/ATP 1.10 1.22 .70 .85 .69 .64 .60
Stub1
KLA  ATP  ATP+KLA
 NM_019719 STIP1 homology and U-Box containing protein 1 (Stub1), mRNA [NM_019719] KLA .73 .76 .75 .67 .76 .72 .86
ATP 1.07 1.15 .86 1.04 .96 .70 .84
KLA/ATP .77 .84 .67 .82 .68 .71 .73
Syvn1
KLA  ATP  ATP+KLA
 NM_028769 synovial apoptosis inhibitor 1, synoviolin (Syvn1), mRNA [NM_028769] KLA 1.33 1.36 1.25 1.15 1.33 1.28 1.39
ATP 1.05 1.08 1.01 .90 .89 1.27 1.19
KLA/ATP 1.35 1.29 1.17 1.08 1.13 1.34 1.40
Tloc1
KLA  ATP  ATP+KLA
 NM_027016 translocation protein 1 (Tloc1), mRNA [NM_027016] KLA 1.04 1.09 1.05 1.01 .94 .86 .92
ATP 1.05 1.10 1.11 1.03 .87 .76 .73
KLA/ATP 1.06 1.12 1.04 1.07 .88 .70 .54
Traf2
KLA  ATP  ATP+KLA
 NM_009422 Tnf receptor-associated factor 2 (Traf2), mRNA [NM_009422] KLA 3.38 3.62 3.49 3.36 3.49 3.39 2.68
ATP .97 1.04 1.00 1.10 1.54 2.40 1.55
KLA/ATP 3.38 3.16 2.93 2.74 2.67 3.11 4.70
Tram1
KLA  ATP  ATP+KLA
 NM_028173 translocating chain-associating membrane protein 1 (Tram1), mRNA [NM_028173] KLA .91 .92 .86 .84 .80 .80 1.10
ATP 1.09 1.20 1.02 1.21 .89 .78 1.62
KLA/ATP .93 .99 .80 .90 .61 .67 1.41
Tusc3
KLA  ATP  ATP+KLA
 BC003311 tumor suppressor candidate 3, mRNA (cDNA clone IMAGE:3154952), complete cds. [BC003311] KLA 1.07 1.13 1.27 1.18 1.14 .99 .91
ATP 1.09 1.02 .96 1.10 .92 .82 1.13
KLA/ATP 1.17 1.25 .97 .96 .73 .71 .91
Tusc3
KLA  ATP  ATP+KLA
 NM_030254 tumor suppressor candidate 3 (Tusc3), mRNA [NM_030254] KLA 1.28 1.26 1.13 1.34 1.18 1.05 .79
ATP .99 .91 1.18 .99 .84 1.14 1.04
KLA/ATP 1.00 1.11 1.42 1.06 .81 .84 .95
Txndc5
KLA  ATP  ATP+KLA
 NM_145367 thioredoxin domain containing 5 (Txndc5), mRNA [NM_145367] KLA 1.01 1.03 1.01 .93 .95 .86 .90
ATP 1.07 1.26 .99 1.37 .96 .78 .95
KLA/ATP 1.05 1.15 .83 1.17 .71 .76 .64
Ube2d1
KLA  ATP  ATP+KLA
 NM_145420 ubiquitin-conjugating enzyme E2D 1, UBC4/5 homolog (yeast) (Ube2d1), mRNA [NM_145420] KLA 1.74 2.10 2.22 1.61 1.21 1.02 1.06
ATP 1.17 1.45 .96 1.24 .68 .84 1.00
KLA/ATP 2.41 2.30 1.05 2.18 .84 1.02 1.32
Ube2d2
KLA  ATP  ATP+KLA
 NM_019912 ubiquitin-conjugating enzyme E2D 2 (Ube2d2), mRNA [NM_019912] KLA 1.29 1.29 1.41 1.23 1.36 1.30 1.31
ATP 1.07 1.17 1.00 1.15 1.11 1.28 1.04
KLA/ATP 1.38 1.39 .99 1.29 1.05 1.26 1.38
Ube2d3
KLA  ATP  ATP+KLA
 NM_025356 ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) (Ube2d3), mRNA [NM_025356] KLA 1.72 1.77 1.76 1.74 1.73 1.55 1.38
ATP .98 1.14 1.06 1.22 1.45 1.85 1.13
KLA/ATP 1.64 1.62 1.41 1.80 1.60 1.97 1.74
Ube2e1
KLA  ATP  ATP+KLA
 NM_009455 ubiquitin-conjugating enzyme E2E 1, UBC4/5 homolog (yeast) (Ube2e1), mRNA [NM_009455] KLA 2.67 2.73 2.80 2.73 2.69 2.25 1.09
ATP .97 1.09 1.20 1.30 .97 .70 .67
KLA/ATP 2.41 2.82 2.81 3.36 2.55 1.99 .66
Ube2e2
KLA  ATP  ATP+KLA
 AK044807 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130003A05 product:unclassifiable, full insert sequence. [AK044807] KLA 2.38 2.04 2.04 1.47 1.69 1.32 1.21
ATP 1.29 1.95 3.29 2.85 3.11 1.82 .85
KLA/ATP 2.50 2.57 3.10 1.78 1.74 1.21 .91
Ube2e2
KLA  ATP  ATP+KLA
 NM_144839 ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) (Ube2e2), mRNA [NM_144839] KLA 2.97 2.73 2.87 3.45 2.77 1.98 1.24
ATP 1.04 .95 1.27 1.24 1.26 1.42 .68
KLA/ATP 2.64 3.10 3.67 3.17 3.00 1.50 .66
Ube2e3
KLA  ATP  ATP+KLA
 AK043446 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730096E21 product:unclassifiable, full insert sequence [AK043446] KLA .89 .98 .94 .95 .98 .97 1.04
ATP .96 .95 .98 .93 .97 .96 .92
KLA/ATP 1.01 .98 .90 .86 .81 .90 1.10
Ube2e3
KLA  ATP  ATP+KLA
 NM_009454 ubiquitin-conjugating enzyme E2E 3, UBC4/5 homolog (yeast) (Ube2e3), mRNA [NM_009454] KLA 1.04 .98 .94 .78 .67 .81 1.13
ATP .93 .92 1.02 1.04 .80 .66 .99
KLA/ATP 1.01 .92 .87 .91 .68 .57 .81
Ube2g1
KLA  ATP  ATP+KLA
 NM_025985 ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, C. elegans) (Ube2g1), mRNA [NM_025985] KLA 1.01 .97 .95 .79 .93 1.19 1.44
ATP 1.12 1.24 1.07 1.18 1.82 2.36 1.29
KLA/ATP 1.02 1.06 .80 1.06 1.59 2.40 1.85
Ube2g2
KLA  ATP  ATP+KLA
 NM_019803 ubiquitin-conjugating enzyme E2G 2 (Ube2g2), mRNA [NM_019803] KLA .67 .68 .71 .74 .88 1.15 1.22
ATP .99 1.06 1.06 1.16 1.56 1.24 1.08
KLA/ATP .67 .72 .78 .74 1.04 1.22 1.03
Ube2j1
KLA  ATP  ATP+KLA
 NM_019586 ubiquitin-conjugating enzyme E2, J1 (Ube2j1), mRNA [NM_019586] KLA 1.36 1.31 1.41 1.35 1.28 1.42 1.42
ATP 1.09 1.11 1.15 1.19 1.63 2.57 1.53
KLA/ATP 1.41 1.44 1.43 1.42 1.59 2.08 1.94
Ube2j2
KLA  ATP  ATP+KLA
 NM_021402 ubiquitin-conjugating enzyme E2, J2 homolog (yeast) (Ube2j2), transcript variant 1, mRNA [NM_021402] KLA 1.20 1.08 1.25 1.17 1.28 1.25 1.56
ATP 1.11 1.09 .97 1.17 1.45 1.67 1.49
KLA/ATP 1.22 1.16 1.00 .97 1.18 1.63 1.68
Ube4b
KLA  ATP  ATP+KLA
 NM_022022 ubiquitination factor E4B, UFD2 homolog (S. cerevisiae) (Ube4b), mRNA [NM_022022] KLA 1.41 1.36 1.28 .90 .78 .88 1.12
ATP 1.09 1.17 .96 1.08 1.14 1.41 .97
KLA/ATP 1.55 1.45 .98 .90 .80 1.40 1.24
Ubqln1
KLA  ATP  ATP+KLA
 AF177345 PLIC-1 mRNA, complete cds. [AF177345] KLA 1.49 1.49 1.53 1.38 1.41 1.61 1.74
ATP .98 1.17 1.08 1.29 1.34 1.77 1.66
KLA/ATP 1.43 1.62 1.27 1.71 1.37 1.91 2.22
Ubqln1
KLA  ATP  ATP+KLA
 NM_026842 ubiquilin 1 (Ubqln1), transcript variant 1, mRNA [NM_026842] KLA 1.05 1.11 1.06 .91 .87 .89 1.16
ATP .98 1.15 .85 .97 .90 .69 .66
KLA/ATP 1.10 1.16 .77 .88 .68 .60 .50
Ubqln1
KLA  ATP  ATP+KLA
 NM_152234 ubiquilin 1 (Ubqln1), transcript variant 2, mRNA [NM_152234] KLA 1.40 1.46 1.45 1.42 1.30 1.48 1.73
ATP 1.01 1.11 1.16 1.20 1.35 1.91 1.63
KLA/ATP 1.45 1.46 1.29 1.46 1.28 1.85 2.10
Ubqln2
KLA  ATP  ATP+KLA
 NM_018798 ubiquilin 2 (Ubqln2), mRNA [NM_018798] KLA .76 .69 .65 .49 .50 .51 .68
ATP 1.23 1.39 1.14 1.08 .97 .98 .86
KLA/ATP .71 .84 .62 .76 .60 .68 .60
Ubqln3
KLA  ATP  ATP+KLA
 NM_198623 ubiquilin 3 (Ubqln3), mRNA [NM_198623] KLA .97 .94 1.03 .98 .94 1.02 1.05
ATP .98 .98 1.02 .98 .98 .99 .89
KLA/ATP 1.05 1.05 .99 1.04 .93 1.02 .93
Ubqln4
KLA  ATP  ATP+KLA
 NM_033526 ubiquilin 4 (Ubqln4), mRNA [NM_033526] KLA 1.04 1.03 1.16 .91 .80 .70 1.11
ATP 1.24 1.42 .96 1.44 1.10 .92 .77
KLA/ATP 1.32 1.44 .88 1.14 .89 .79 .98
Ubqlnl
KLA  ATP  ATP+KLA
 NM_198624 ubiquilin-like (Ubqlnl), mRNA [NM_198624] KLA .95 1.00 1.00 1.01 1.00 .95 1.07
ATP 1.03 .99 .96 1.02 .96 .96 1.04
KLA/ATP .98 1.00 1.00 .99 .96 1.00 .98
Ubxd1
KLA  ATP  ATP+KLA
 NM_024432 UBX domain containing 1 (Ubxd1), mRNA [NM_024432] KLA .90 .88 .82 .96 .95 1.02 1.26
ATP .99 1.11 1.06 1.10 1.09 1.22 1.09
KLA/ATP .81 .83 .96 1.02 .97 1.04 1.46
Ufd1l
KLA  ATP  ATP+KLA
 NM_011672 ubiquitin fusion degradation 1 like (Ufd1l), mRNA [NM_011672] KLA 1.20 1.18 1.25 1.19 1.26 1.22 1.26
ATP 1.01 1.05 .98 1.16 1.09 1.31 1.27
KLA/ATP 1.30 1.24 1.12 1.33 1.10 1.29 1.52
Ugcgl1
KLA  ATP  ATP+KLA
 AK134231 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830496D18 product:unclassifiable, full insert sequence [AK134231] KLA .84 .82 .76 .66 .61 .50 .47
ATP 1.01 .97 1.19 .92 .80 .55 .42
KLA/ATP .83 .85 .93 .65 .58 .40 .29
Ugcgl1
KLA  ATP  ATP+KLA
 NM_198899 UDP-glucose ceramide glucosyltransferase-like 1 (Ugcgl1), mRNA [NM_198899] KLA .96 1.00 1.02 .79 .69 .61 .63
ATP 1.05 1.26 1.02 1.15 .81 .57 .66
KLA/ATP 1.12 1.15 .89 .91 .50 .41 .41
Ugcgl2
KLA  ATP  ATP+KLA
 AK007954 10 day old male pancreas cDNA, RIKEN full-length enriched library, clone:1810064L21 product:hypothetical Endoplasmic reticulum targeting sequence containing protein, full insert sequence. [AK007954] KLA .86 .87 .86 .77 .78 .75 .93
ATP .97 1.02 1.06 1.03 .72 .69 .77
KLA/ATP .79 .81 .88 .86 .75 .71 .70
Ugcgl2
KLA  ATP  ATP+KLA
 NM_001081252 UDP-glucose ceramide glucosyltransferase-like 2 (Ugcgl2), mRNA [NM_001081252] KLA .97 .94 .97 .95 .93 .91 .98
ATP 1.00 .99 1.00 .98 .91 .91 .95
KLA/ATP .95 .97 1.01 .94 .94 .90 .90
Vcp
KLA  ATP  ATP+KLA
 NM_009503 valosin containing protein (Vcp), mRNA [NM_009503] KLA .89 .99 .95 .88 .92 .97 1.04
ATP 1.03 1.02 .80 .71 1.05 1.42 .74
KLA/ATP .99 1.02 .79 .71 .85 1.05 .65
Wfs1
KLA  ATP  ATP+KLA
 NM_011716 Wolfram syndrome 1 homolog (human) (Wfs1), mRNA [NM_011716] KLA .97 .95 .98 1.04 .97 .89 .89
ATP .97 .95 1.03 .73 2.28 1.62 1.40
KLA/ATP .95 .95 1.02 1.10 5.84 3.88 .89
Xbp1
KLA  ATP  ATP+KLA
 NM_013842 X-box binding protein 1 (Xbp1), mRNA [NM_013842] KLA .95 .98 1.13 1.28 1.50 .97 1.46
ATP 1.32 1.37 .75 .85 .97 .77 1.22
KLA/ATP 1.16 1.29 .80 1.08 .81 .97 .88
Yod1
KLA  ATP  ATP+KLA
 NM_178691 YOD1 OTU deubiquitinating enzyme 1 homologue (S. cerevisiae) (Yod1), mRNA [NM_178691] KLA 1.31 1.19 1.41 1.21 1.38 1.39 1.11
ATP 1.05 .89 .87 .73 1.31 1.34 .95
KLA/ATP 1.23 1.09 .99 .77 1.34 1.04 1.08
Yy2
KLA  ATP  ATP+KLA
 NM_001098723 Yy2 transcription factor (Yy2), mRNA [NM_001098723] KLA 1.45 1.56 1.69 1.41 1.16 1.07 1.20
ATP 1.20 1.34 1.28 1.18 .75 .75 .83
KLA/ATP 1.51 1.55 1.19 1.40 .78 .65 .77